<DOC>
	<DOC>NCT00388882</DOC>
	<brief_summary>The objective of this study is to evaluate the efficacy and safety of 12 weeks treatment with tiotro pium HandiHaler® 18 mcg daily compared to Combivent® MDI CFC Inhalation Aerosol 2 actuations qid in COPD patients currently prescribed Combivent® MDI.</brief_summary>
	<brief_title>Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Diagnosis of COPD Age: &gt;= 40 years Current or exsmoker with a &gt;= 10 packyear smoking history Use of Combivent® MDI for &gt;= 1 month prior to Visit 1 Spirometric criteria (determined at study visits): Postbronchodilator FEV1 &lt;= 70% (Visit 1) Prebronchodilator FEV1 &lt;= 65% of predicted and FEV1/FVC &lt;= 70% (Visit 2) Clinical history of asthma History of thoracotomy with pulmonary resection History of CF, alpha 1 antitrypsin deficiency or interstitial lung disease Daytime use of oxygen therapy for &gt; 1 hour per day or if unable to abstain from using oxygen during PFTs Any respiratory tract infection or COPD exacerbation in 6 weeks prior to Visit 1 Recent history 6 months or less of MI Unstable or lifethreatening cardiac arrhythmias Hospitalization for CHF during past year Malignancy for which patient is receiving chemo or radiation therapy Pregnant or nursing women Known hypersensitivity to ipratropium or carrier substances, including related food products such as soybean, peanuts, or lactose Use of SPIRIVA® 3 months prior to Visit 1 Symptomatic of prostatic hypertrophy or bladder neck obstruction Known narrow angle glaucoma Participating in a pulmonary rehab program within 4 weeks of Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>